Venus Remedies Limited has informed the Exchange regarding a press release dated Jun 01, 2023, titled "Venus Remedies consolidates its position in oncology space with Saudi marketing approval for Docetaxel.".
Press Release Jun 01 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Venus Remedies
- Press Release May 23 2023
- Press Release May 16 2023
- Press Release May 09 2023
- Press Release Apr 25 2023
- Press Release (Revised) Mar 06 2023
Later from Venus Remedies
- Press Release Jun 07 2023
- Press Release Jun 22 2023
- Press Release Jul 05 2023
- Press Release Jul 31 2023
- Press Release Aug 17 2023
Follow Venus Remedies into a list and get an email when it puts out news.
Follow Venus Remedies